Faslodex
Faslodex is a medicine authorised by Swissmedic under authorisation number 56778. The authorisation holder is AstraZeneca AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 March 2004 and the authorisation is valid without a time limit. ATC code L02BA03 places the medicine in the group Endocrine therapy.
| Authorisation number | 56778 |
|---|---|
| Name | Faslodex |
| Full name | Faslodex, Injektionslösung |
| Authorisation holder | AstraZeneca AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L02BA03 |
| First authorisation | 19 March 2004 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Faslodex, Injektionslösung | B | 19 March 2004 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 12 | 2 | Spritze(n) | L02BA03 | 07.16.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Faslodex authorised in Switzerland?
Yes. Faslodex is authorised by Swissmedic under authorisation number 56778, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Faslodex have?
Faslodex is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Faslodex?
The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.